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Background
Although vaccination with live attenuated SIV is the
most effective means of inducing protection against len-
tiviruses, the immunologic mechanisms responsible
remain unclear. Previous studies have yielded conflicting
data regarding the role of adaptive immune responses in
mediating protection, suggesting that innate immune
responses, including natural killer (NK) cells, may play a
role.
Methods
Rhesus macaques were vaccinated with SIVΔnef and
challenged with SIVmac239. Cellular dynamics were
measured by polychromatic flow cytometry and absolute
counts of lymphocytes in blood and rectal biopsies were
determined by a bead-based, flow cytometry assay.
Results
Following SIVΔnef vaccination, circulating NK cells
increased 8-fold, peaking at 2 weeks post-vaccination
and preceding SIV-specific T cell responses. Further-
more, the gut-homing marker a4b7 was upregulated on
circulating NK cells, coinciding with a 2.5-fold increase
in NK cells in colorectal tissue. Ki67 expression was
upregulated 2- to 5-fold in circulating, lymphoid, and
mucosal NK cells. NK cell expansion was also stratified
by MHC genotype — Mamu A*01+ macaques showed
significant and sustained expansion of NK cells, but not
Mamu A*02+ or Mamu B*17+ macaques. SIVΔnef also
induced a significant expansion of KIR+ and cytotoxic
NK cells in the colorectal mucosa. Interestingly, in vac-
cinated macaques challenged with wild-type SIV, a4b7
and Ki67 were both upregulated in circulating and
mucosal NK cells, even in protected animals and in the
absence of an obvious anamnestic response.
Conclusion
Although current lentiviral vaccines stress the impor-
tance of induction of SIV-specific T and B cell
responses, NK cells could contribute to protection by
inhibiting initial rounds of wild-type virus replication in
the mucosa. Our data indicate SIVΔnef induces a robust
and sustained expansion of NK cells that traffic to the
g u tm u c o s a ,a n dt h a tt h ep r o t e c t i v eS I V Δnef NK
responses may be modulated, in part, by interaction of
Mamu A*01 with an as of yet unidentified KIR.
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